Literature DB >> 24625437

KeraSkin-VM: a novel reconstructed human epidermis model for skin irritation tests.

Kyoung-Mi Jung1, Su-Hyon Lee2, Won-Hee Jang1, Haeng-Sun Jung2, Yong Heo3, Young-Ho Park1, SeungJin Bae4, Kyung-Min Lim5, Seung Hyeok Seok6.   

Abstract

Several alternative in vitro methods to evaluate skin irritants have been developed recently. In July 2010, OECD officially endorsed the validated reference method (VRM) that uses reconstituted human epidermis (RhE) models as replacements for the in vivo skin irritation test. This study evaluated the KeraSkin-VM model, a novel human epidermis model that was reconstructed with Asian skin tissue using 20 reference chemicals according to the OECD TG 439 performance standard. The test chemicals were applied to the epidermal surface side for 45 min and then rinsed, and then incubated for 42 h post-treatment. An overall accuracy of 80%, sensitivity of 90% and specificity of 70% were obtained when the results from KeraSkin-VM were compared with UN GHS categories, which was comparable to the EpiDerm Skin irritation test (SIT) rates. Furthermore, KeraSkin-VM demonstrated good performance in terms of within-laboratory reproducibility and predictive capacity to screen skin irritants.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Accuracy; Keraskin™-VM; Reconstructed human skin; Sensitivity; Skin irritation; Specificity

Mesh:

Substances:

Year:  2014        PMID: 24625437     DOI: 10.1016/j.tiv.2014.02.014

Source DB:  PubMed          Journal:  Toxicol In Vitro        ISSN: 0887-2333            Impact factor:   3.500


  15 in total

1.  Structural and Functional Validation of a Full-Thickness Self-Assembled Skin Equivalent for Disease Modeling.

Authors:  Bo Ram Mok; Su-Ji Shon; A Ram Kim; Carolyne Simard-Bisson; Israël Martel; Lucie Germain; Dong Hyun Kim; Jung U Shin
Journal:  Pharmaceutics       Date:  2022-06-07       Impact factor: 6.525

2.  A Web-based Alternative Non-animal Method Database for Safety Cosmetic Evaluations.

Authors:  Seung Won Kim; Bae-Hwan Kim
Journal:  Toxicol Res       Date:  2016-07-30

Review 3.  Alternatives to In Vivo Draize Rabbit Eye and Skin Irritation Tests with a Focus on 3D Reconstructed Human Cornea-Like Epithelium and Epidermis Models.

Authors:  Miri Lee; Jee-Hyun Hwang; Kyung-Min Lim
Journal:  Toxicol Res       Date:  2017-07-15

4.  Anti-Pigmentary Effect of (-)-4-Hydroxysattabacin from the Marine-Derived Bacterium Bacillus sp.

Authors:  Kyuri Kim; Alain S Leutou; Haein Jeong; Dayoung Kim; Chi Nam Seong; Sang-Jip Nam; Kyung-Min Lim
Journal:  Mar Drugs       Date:  2017-05-13       Impact factor: 5.118

5.  Microfluidics-based skin irritation test using in vitro 3D angiogenesis platform.

Authors:  Norhana Jusoh; Jihoon Ko; Noo Li Jeon
Journal:  APL Bioeng       Date:  2019-07-29

6.  Lysates of a Probiotic, Lactobacillus rhamnosus, Can Improve Skin Barrier Function in a Reconstructed Human Epidermis Model.

Authors:  Ye-On Jung; Haengdueng Jeong; Yejin Cho; Eun-Ok Lee; Hye-Won Jang; Jinwook Kim; Kitaek Nam; Kyung-Min Lim
Journal:  Int J Mol Sci       Date:  2019-09-02       Impact factor: 5.923

7.  Improvement of a Three-Layered in vitro Skin Model for Topical Application of Irritating Substances.

Authors:  Freia F Schmidt; Sophia Nowakowski; Petra J Kluger
Journal:  Front Bioeng Biotechnol       Date:  2020-05-08

8.  Effect of AgNPs on the human reconstructed epidermis.

Authors:  Jana Franková; Jana Juráňová; Vojtěch Kamarád; Bohumil Zálešák; Jitka Ulrichová
Journal:  Interdiscip Toxicol       Date:  2019-10-18

9.  Evaluation of Eye Irritation Potential of Solid Substance with New 3D Reconstructed Human Cornea Model, MCTT HCE(TM).

Authors:  Won-Hee Jang; Kyoung-Mi Jung; Hye-Ri Yang; Miri Lee; Haeng-Sun Jung; Su-Hyon Lee; Miyoung Park; Kyung-Min Lim
Journal:  Biomol Ther (Seoul)       Date:  2015-07-01       Impact factor: 4.634

10.  Preparation and evaluation of microemulsion-based transdermal delivery of total flavone of rhizoma arisaematis.

Authors:  Li-Na Shen; Yong-Tai Zhang; Qin Wang; Ling Xu; Nian-Ping Feng
Journal:  Int J Nanomedicine       Date:  2014-07-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.